Read More 3 minute read FFinance Is Merck Stock a Bargain Buy?bytadyMarch 27, 2025 Merck (MRK 0.32%) is a top healthcare company with one of the best drugs ever made in its…
Read More 2 minute read FFinance Pfizer Mulls US Manufacturing Shift Amid Looming Tariff Threats. ‘Will The Trump Administration Co-Invest’, Asks Analyst – Merck & Co (NYSE:MRK), Eli Lilly (NYSE:LLY)bytadyMarch 4, 2025 In light of potential tariff threats from President Donald Trump, Pfizer Inc.’s PFE CEO Albert Bourla has suggested…
Read More 4 minute read FFinance Merck Stock’s Drop Could Be a Golden Buying OpportunitybytadyFebruary 10, 2025 Merck & Co., Inc. Today MRK Merck & Co., Inc. $87.79 +0.51 (+0.59%) As of 11:45 AM Eastern This…
Read More 2 minute read FFinance Why Merck Stock Is Plummeting TodaybytadyFebruary 4, 2025 Shares of Merck (MRK -9.81%) were trading lower on Tuesday. The company’s stock had lost 10.1% as of…
Read More 1 minute read FFinance Merck: Ideal Case Of Why I Love Option Collars (Upgrade To Buy) (NYSE:MRK)bytadyFebruary 4, 2025 This article was written by Follow I’m Rob Isbitts, founder of Sungarden Investment Publishing. I run the new…
Read More 2 minute read FFinance Merck & Co. Inc. (MRK) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)bytadyJanuary 14, 2025 Merck & Co. Inc. (NYSE:MRK) 43rd Annual J.P. Morgan Healthcare Conference January 13, 2025 7:30 PM ET Company…
Read More 2 minute read FFinance UK Approves Merck’s Hypertension Drug Acquired Via $11 Billion Acceleron Pharma Deal – Merck & Co (NYSE:MRK)bytadyJanuary 2, 2025 Last Friday, the Medicines and Healthcare Products Regulatory Agency approved Merck & Co Inc’s MRK Winrevair (sotatercept) for…
Read More 3 minute read FFinance 2 Reasons to Sell Merck Stock and 1 Reason to BuybytadyDecember 27, 2024 There is plenty to like about Merck (MRK 0.42%). It is one of the largest pharmaceutical companies and…
Read More 2 minute read FFinance Merck’s Investigational Two-Drug Regime For HIV Meets Primary Goal In Two Late-Stage Trials – Merck & Co (NYSE:MRK)bytadyDecember 19, 2024 On Thursday, Merck & Co Inc MRK revealed topline results from two pivotal Phase 3 trials of a two-drug…